{
    "2018-10-02": [
        [
            {
                "time": "2018-10-02",
                "original_text": "Health Care Sector Update for 10/02/2018: MMSI,JNJ,LLY",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "MMSI",
                        "JNJ",
                        "LLY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "Examining the Performances of Eli Lilly’s Oncology Products",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Oncology Products"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "Health Care Sector Update for 10/02/2018: JNJ,LLY",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "JNJ",
                        "LLY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "How Eli Lilly’s Cardiovascular Products Have Been Faring",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Cardiovascular Products"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "Migraine sufferers: Help is on the way from 3 new drugs, but they’ll cost $6,900 a year",
                "features": {
                    "keywords": [
                        "Migraine",
                        "drugs",
                        "cost"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly And Co.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "Stocks making the biggest move premarket: PEP, AMZN, SFIX, CVX & more",
                "features": {
                    "keywords": [
                        "Stocks",
                        "premarket",
                        "PEP",
                        "AMZN",
                        "SFIX",
                        "CVX"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "various"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "Does Mylan’s Low Valuation Provide a ‘Buy’ Opportunity?",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Low Valuation",
                        "Buy Opportunity"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "A Closer Look at Eli Lilly’s Human Pharmaceutical Business",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Human Pharmaceutical Business"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "Eli Lilly's diabetes treatment meets main goal in two late-stage studies",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "diabetes treatment",
                        "late-stage studies"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "Results from Two Phase 3 Studies Show Lilly's Ultra Rapid Lispro (URLi) Met Primary Efficacy Endpoint in People with Type 1 and Type 2 Diabetes",
                "features": {
                    "keywords": [
                        "Phase 3 Studies",
                        "Lilly",
                        "Ultra Rapid Lispro",
                        "Type 1",
                        "Type 2 Diabetes"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "Eli Lilly: Phase 3 Studies Show URLi Meets Primary Efficacy Endpoint",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Phase 3 Studies",
                        "URLi",
                        "Primary Efficacy Endpoint"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}